Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
- PMID: 28184416
- PMCID: PMC5452071
- DOI: 10.1093/annonc/mdx054
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
Abstract
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.
Keywords: chemotherapy; chordoma; radiotherapy; relapse; sarcoma; surgery.
© The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
Figures
Similar articles
-
Building a global consensus approach to chordoma: a position paper from the medical and patient community.Lancet Oncol. 2015 Feb;16(2):e71-83. doi: 10.1016/S1470-2045(14)71190-8. Lancet Oncol. 2015. PMID: 25638683
-
Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.Oper Neurosurg. 2019 Jan 1;16(1):27-36. doi: 10.1093/ons/opy073. Oper Neurosurg. 2019. PMID: 29912434
-
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.ESMO Open. 2021 Jun;6(3):100170. doi: 10.1016/j.esmoop.2021.100170. Epub 2021 Jun 2. ESMO Open. 2021. PMID: 34090171 Free PMC article. Review.
-
Chordoma: the nonsarcoma primary bone tumor.Oncologist. 2007 Nov;12(11):1344-50. doi: 10.1634/theoncologist.12-11-1344. Oncologist. 2007. PMID: 18055855 Review.
-
Contemporary management of clival chordomas.Curr Opin Otolaryngol Head Neck Surg. 2015 Apr;23(2):153-61. doi: 10.1097/MOO.0000000000000140. Curr Opin Otolaryngol Head Neck Surg. 2015. PMID: 25692630 Review.
Cited by
-
Research hotspots and trends of chordoma: A bibliometric analysis.Front Oncol. 2022 Sep 16;12:946597. doi: 10.3389/fonc.2022.946597. eCollection 2022. Front Oncol. 2022. PMID: 36185236 Free PMC article.
-
Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis.J Neurol Surg B Skull Base. 2022 Feb 17;84(1):60-68. doi: 10.1055/a-1733-9475. eCollection 2023 Feb. J Neurol Surg B Skull Base. 2022. PMID: 36743709 Free PMC article.
-
Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature Review.Cancers (Basel). 2023 Sep 9;15(18):4493. doi: 10.3390/cancers15184493. Cancers (Basel). 2023. PMID: 37760463 Free PMC article.
-
Mid-term follow-up surgical results in 284 cases of clival chordomas: the risk factors for outcome and tumor recurrence.Neurosurg Rev. 2022 Apr;45(2):1451-1462. doi: 10.1007/s10143-021-01576-4. Epub 2021 Oct 8. Neurosurg Rev. 2022. PMID: 34623525 Free PMC article.
-
[Notochordal tumors : Benign notochordal tumors and chordomas].Pathologe. 2018 Mar;39(2):117-124. doi: 10.1007/s00292-017-0399-1. Pathologe. 2018. PMID: 29236139 Review. German.
References
-
- Flanagan AM, Yamaguchi T, Chordoma In Fletcher CDM, Bridge JA, Pancras CW, Mertens F (eds), World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone. Pathology and Genetics. Lyon: IARC Press; 2013; 328–329.
-
- Stacchiotti S, Sommer J. on behalf of a Chordoma Global Consensus Group. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol 2015; 16: 71–83. - PubMed
-
- Weber DC, Malyapa R, Albertini F. et al. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol 2016; 120: 169–174. - PubMed
-
- Tzortzidis F, Elahi F, Wright D. et al. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 2006; 59: 230–237. - PubMed
-
- Cloyd JM, Acosta FL Jr, Polley MY. et al. En bloc resection for primary and metastatic tumors of the spine: a systematic review of the literature. Neurosurgery 2010; 67: 435–444. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
- Andalusian Health Repository - access to free full text
- Archivio Istituzionale della Ricerca Unimi - Access Free Full Text
- Bern Open Repository and Information System
- Digital CSIC Spanish National Research Council - Access Free Full Text
- Elsevier Science
- Europe PubMed Central
- Ovid Technologies, Inc.
- PubMed Central
Other Literature Sources